FDA-Inspected Site

Zhejiang Jingxin Pharmaceutical Co., Ltd

3 FDA inspections are on record for Zhejiang Jingxin Pharmaceutical Co., Ltd in Shaoxing, China.

483· Form 483 issued

Shaoxing, China · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-10-17.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
13 Oct 2025 – 17 Oct 2025Human Drugs483View 483 →
17 Jun 2024 – 21 Jun 2024Human DrugsClean
5 Nov 2018 – 9 Nov 2018Human Drugs483On file

Observations on record

Form 483 observations cited at this site, most recent first.

17 Oct 2025
21 CFR 211.165(b)

Microbiological testing

Cited by Carolina D Vasquez

17 Oct 2025
21 CFR 211.84(d)(1)

Identity Testing of Each Component

Cited by Carolina D Vasquez

Investigators

FDA investigators tied to this site in the record.

Tekalign Wondimu1 insp.
Joel D Hustedt1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Zhejiang Jingxin Pharmaceutical Co., Ltd's 2 Form 483s

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites